Michael L. Meyers
2019
In 2019, Michael L. Meyers earned a total compensation of $818.5K as Chief Medical Officer at Syndax Pharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,770 |
|---|---|
| Option Awards | $219,173 |
| Salary | $424,360 |
| Other | $22,169 |
| Total | $818,472 |
Meyers received $424.4K in salary, accounting for 52% of the total pay in 2019.
Meyers also received $152.8K in non-equity incentive plan, $219.2K in option awards and $22.2K in other compensation.
Rankings
In 2019, Michael L. Meyers' compensation ranked 10,118th out of 13,971 executives tracked by ExecPay. In other words, Meyers earned more than 27.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,118 out of 13,971 | 28th |
Division Manufacturing | 4,086 out of 5,695 | 28th |
Major group Chemicals And Allied Products | 1,550 out of 2,194 | 29th |
Industry group Drugs | 1,327 out of 1,880 | 29th |
Industry Pharmaceutical Preparations | 988 out of 1,392 | 29th |
Source: SEC filing on April 29, 2020.
Meyers' colleagues
We found two more compensation records of executives who worked with Michael L. Meyers at Syndax Pharmaceuticals in 2019.